These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. A crucial role for B and T lymphocyte attenuator in preventing the development of CD4+ T cell-mediated herpetic stromal keratitis. Xia L; Zhang S; Zhou J; Li Y Mol Vis; 2010 Oct; 16():2071-83. PubMed ID: 21042564 [TBL] [Abstract][Full Text] [Related]
8. Azacytidine Treatment Inhibits the Progression of Herpes Stromal Keratitis by Enhancing Regulatory T Cell Function. Varanasi SK; Reddy PBJ; Bhela S; Jaggi U; Gimenez F; Rouse BT J Virol; 2017 Apr; 91(7):. PubMed ID: 28100624 [TBL] [Abstract][Full Text] [Related]
9. CD4+CD25+ regulatory T cells control the severity of viral immunoinflammatory lesions. Suvas S; Azkur AK; Kim BS; Kumaraguru U; Rouse BT J Immunol; 2004 Apr; 172(7):4123-32. PubMed ID: 15034024 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of Corneal Inflammation by the Resolvin E1. Lee JE; Sun Y; Gjorstrup P; Pearlman E Invest Ophthalmol Vis Sci; 2015 Apr; 56(4):2728-36. PubMed ID: 25758817 [TBL] [Abstract][Full Text] [Related]
11. Application of our understanding of pathogenesis of herpetic stromal keratitis for novel therapy. Rajasagi NK; Rouse BT Microbes Infect; 2018; 20(9-10):526-530. PubMed ID: 29329934 [TBL] [Abstract][Full Text] [Related]
12. Plasmid DNA encoding IFN-alpha 1 antagonizes herpes simplex virus type 1 ocular infection through CD4+ and CD8+ T lymphocytes. Noisakran S; Carr DJ J Immunol; 2000 Jun; 164(12):6435-43. PubMed ID: 10843699 [TBL] [Abstract][Full Text] [Related]
13. Resolvin E1 improves tear production and decreases inflammation in a dry eye mouse model. Li N; He J; Schwartz CE; Gjorstrup P; Bazan HE J Ocul Pharmacol Ther; 2010 Oct; 26(5):431-9. PubMed ID: 20874497 [TBL] [Abstract][Full Text] [Related]
14. Application of plasmid DNA encoding IL-18 diminishes development of herpetic stromal keratitis by antiangiogenic effects. Kim B; Lee S; Suvas S; Rouse BT J Immunol; 2005 Jul; 175(1):509-16. PubMed ID: 15972686 [TBL] [Abstract][Full Text] [Related]
15. Resolvin E1 Inhibits Corneal Allograft Rejection in High-Risk Corneal Transplantation. Wang H; Zhao Q; Luo D; Yin Y; Li T; Zhao M Invest Ophthalmol Vis Sci; 2018 Aug; 59(10):3911-3919. PubMed ID: 30073362 [TBL] [Abstract][Full Text] [Related]
16. Vascular endothelial growth factor receptor 2-based DNA immunization delays development of herpetic stromal keratitis by antiangiogenic effects. Kim B; Suvas S; Sarangi PP; Lee S; Reisfeld RA; Rouse BT J Immunol; 2006 Sep; 177(6):4122-31. PubMed ID: 16951377 [TBL] [Abstract][Full Text] [Related]
17. Bystander activation of CD4+ T cells accounts for herpetic ocular lesions. Gangappa S; Deshpande SP; Rouse BT Invest Ophthalmol Vis Sci; 2000 Feb; 41(2):453-9. PubMed ID: 10670475 [TBL] [Abstract][Full Text] [Related]
18. Development of Inflammatory Hypoxia and Prevalence of Glycolytic Metabolism in Progressing Herpes Stromal Keratitis Lesions. Rao P; Suvas S J Immunol; 2019 Jan; 202(2):514-526. PubMed ID: 30530484 [TBL] [Abstract][Full Text] [Related]
19. An immunologist's view of herpes simplex keratitis: Thygeson Lecture 1996, presented at the Ocular Microbiology and Immunology Group meeting, October 26, 1996. Hendricks RL Cornea; 1997 Sep; 16(5):503-6. PubMed ID: 9294678 [TBL] [Abstract][Full Text] [Related]
20. Long-term consequences of topical dexamethasone treatment during acute corneal HSV-1 infection on the immune system. Chucair-Elliott AJ; Carr MM; Carr DJJ J Leukoc Biol; 2017 May; 101(5):1253-1261. PubMed ID: 28115476 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]